The Transdermal Drug Delivery Market is being driven by Growing prevalence of chronic diseases
The Transdermal Drug Delivery Market is expected to grow at a CAGR of 4.9% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.44 billion. Transdermal drug delivery systems, represented by patches, offer a non-invasive and convenient alternative to traditional oral and injectable medications. These patches employ advanced transdermal technology, which involves the application of a medical-grade adhesive patch onto the skin to deliver a precise dose of medication. The drug penetrates the skin via a diffusion process, bypassing the gastrointestinal tract, thereby eliminating potential side effects such as nausea and vomiting. This technology's benefits, including increased patient compliance, improved therapeutic efficacy, and reduced healthcare costs, are driving the growing adoption of transdermal drug delivery systems.
Get more information on Transdermal Drug Delivery Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Application (Analgesics, Neurological disorders, Hormone replacement therapy, Cardiovascular disorders, Others) Type (Transdermal patches, Transdermal semisolids) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Transdermal Drug Delivery Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Transdermal Drug Delivery Market encompasses controlled release technology that enables medication adherence through biocompatible patches. FDA approval process ensures drug formulation safety and efficacy for topical medication. Personalized medicine and patient compliance are prioritized with non-invasive, non-pharmaceutical innovation in healthcare. Chronic pain management and alternative pain therapies benefit from this technology's drug stability, skin absorption, and therapeutic benefits. Pharmaceutical industry trends emphasize patch design for improved drug bioavailability, sustained release, and quality of life. Market analysis reveals growth in pharmaceuticals industry through innovation in healthcare, reducing healthcare costs, and patient-centric care using medicinal patches. Future trends include development of patch technology for existing drugs and continued innovation in drug delivery.
The Transdermal Drug Delivery Market is a segment of the larger Global Pharmaceuticals Market, which encompasses entities involved in the research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, veterinary drugs, and related medical equipment and services. According to Technavio's market analysis, the expansion of the global pharmaceuticals market is primarily driven by factors such as an aging population, leading to increased demand for medication, and the growing adoption of pain patches and other advanced transdermal drug delivery systems in medical services. The global healthcare market size is determined by Technavio based on the consolidated revenue generated by providers of pharmaceuticals, biotechnology, life sciences tools and services, and medical equipment and supplies. The global pharmaceuticals market's growth is further fueled by the rising number of elderly individuals, with the global population aged 60 and above projected to significantly increase, necessitating increased healthcare spending and medication usage.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
